BioConverGene Technologies Corporation™

Vision

The rapid and sustained growth of integrative medicine and of affected bio-industries will continue to propel the convergence of protein, DNA and metabolic technologies for the tailoring and manufacturing of less invasive and most efficient primary disease prevention screening, diagnostic and monitoring medical devices and therapies against current and emerging diseases.

Committed to total quality and international regulatory compliance, BioConverGene Technologies™ will continue to translate the benefits of generic and follow-on biologics / subsequent entry biologics into the design manufacturing and commercialization of cell and protein-based converging medical devices and advanced biological therapies for the monitoring, prevention and treatment of pressing chronic, infectious and emerging diseases.